Archive | Health Professionals

Increased survival with eye melanoma in clinical trial

Once it has spread (metastasized), uveal (intraocular or eye) melanoma — an unusual form of cancer — has a very high mortality rate.

Read the full story

Posted in Melanoma News, Health Professionals, Of Interest

Imaging matters when judging ‘risky nevi’

In the past, only clinical factors were used to judge “risky nevi,” but imaging modalities are predictive tools for identifying choroidal nevus risk factors for growth to melanoma, according to Carol L. Shields, MD.

Read the full story

Posted in Melanoma News, Health Professionals, Of Interest

Effects of the COVID-19 pandemic on care of melanoma patients in Berlin, Germany: the Mela-COVID survey

BACKGROUND: The COVID-19 pandemic imposes major challenges for care of cancer patients.

Read the full story

Posted in Melanoma News, Health Professionals, Of Interest

A Phase IB Study of Belvarafenib Alone and in Combination with Cobimetinib in People with Advanced Melanoma Who Had Immunotherapy

The purpose of this study is to find the highest dose of the investigational drug belvarafenib that can be given safely alone and with cobimetinib in people with advanced NRAS-mutated melanoma that continues to grow despite prior treatment with immunotherapy.

Read the full story

Posted in Melanoma News, Health Professionals, Clinical Trials